Compound Q&A
What is the market or research trend for Trabectedin (CAS: 114899-77-3)?
Answer
The market for Trabectedin (CAS: 114899-77-3) is primarily driven by its use in oncology, particularly for the treatment of soft tissue sarcomas and ovarian cancer. Research trends focus on understanding its mechanisms of action and exploring its potential for combination therapies. Additionally, there is ongoing research to develop derivatives and analogs that may improve efficacy and reduce side effects.
About
CAS No
114899-77-3
English Name
Trabectedin
Molecular Formula
C39H43N3O11S
Molecular Weight
761.85 g/mol
SMILES
CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O
InChIKey
PKVRCIRHQMSYJX-AIFWHQITSA-N
Last Updated: 2025-10-17 17:23
